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Background: Newly acquired long-term cognitive impairments are common among
survivors of critical illness. They have been linked to the stressful situation that patients
experience in the intensive care unit (ICU). In this paper we use virtual reality (VR)
technology to comfort critically ill patients and reduce stress during their ICU stay. We
investigate the acceptance, comfort, recollection, and visual perception of VR stimulation
and how it affects physiological parameters.
Methods: A VR head-mounted display was used to present immersive nature scenes
to 33 critically ill cardiac surgery patients [mean age 63 years (range 32–83)]. Data was
collected with an eye tracker fitted inside the VR head-mounted display to measure
eye movements (250Hz) and sensors to record physiological parameters (240Hz).
Patients received VR stimulation (for 5min.) prior to ICU admission, during ICU stay, and
3 months after discharge. Acceptance, recollection and comfort were assessed with
validated questionnaires.
Results: The number of gazed meaningful objects per minute was significantly lower
during the ICU session compared to pre- and follow-up sessions, whereasmean duration
of fixation on meaningful moving objects did not differ between the sessions. While
respiratory rate decreased significantly during VR stimulation, heart rate and blood
pressure remained constant. Post-ICU rating of VR acceptance during ICU stay was
moderate to high and discomfort low. Recollection of VR was high [28/33 patients
(84.8%)], while recollection of ICU stay was low [10/33 patients (30.3%)].
Conclusion: Eye movements indicate that patients were able to perceive and process
cognitive stimulation during their ICU stay. VR was recalled better than the rest of the ICU
stay and well accepted. Decreased respiratory rate during stimulation indicate a relaxing
effect of VR.
Keywords: virtual reality, critical illness, intensive care unit, cognitive dysfunction, nature, stimulation
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INTRODUCTION
The intensive care unit (ICU) is a noisy and stressful environment
in which critically ill patients are exposed to psychological stress
factors, including sensory overload and deprivation, isolation,
temporal disorientation and a feeling of lack of control (1, 2).
After ICU stay, ∼50–75% of all critically ill patients will suffer
from newly acquired long-term cognitive impairment (3–5).
These cognitive long-term effects were linked to the stressful
situation that patients experience during their ICU stay (4, 6).
They negatively affect health-related quality of life after ICU
discharge and reduce the effectiveness of intensive care (7–9).
We therefore embarked to develop a novel strategy using
virtual reality (VR)-based cognitive stimulation technology to
comfort critically ill patients during their stay in the ICU. When
wearing a head-mounted VR display, patients do not hear or see
the ICU and they are virtually “taken out” of the ICU and moved
into a pleasant virtual environment. The virtual environment can
be designed to the needs of immobile critically ill patients and
applied directly in bed.
We decided to present pleasant nature scenes to critically
ill patients because others have shown the beneficial effects of
exposure to nature scenes. A study with 38 healthy participants
described the cognitive benefits (i.e., directed attention) arising
from the interaction with nature (10). In another study, Gamble
et al. found that looking at nature pictures improves executive
attention in older adults (11). There are two complementary
theories related to the restorative effects of natural environments
i.e., positive emotional state, reduced physiological activity level
and increased cognitive functions. The first theory, called the
Attention Restoration Theory, states that directed (i.e., high-
effort) and voluntary (i.e., low-effort) attention, which influences
cognitive performance, is a limited resource and can be depleted
over a prolonged period of time. Directed and voluntary attention
can be restored by interacting with nature environments (11–
13). In rather stressful environments like the ICU, however, one
must be vigilant, causing cognitive functions to decline. The
second theory, the Stress Recovery Theory, postulates that nature
environments reduce fear and anger, and have a stimulating
effect on the parasympathetic nervous system shown in physical
markers of stress (e.g., decreasing respiratory rate) (14). An
established line of research suggests that exploring nature in VR
has a restorative effect, similar to being outside in nature (13).
The state-of-the-art therapy provided to critically ill patients
focuses on physical rehabilitation, and there is currently no
consensus on how to prevent cognitive impairments after ICU
discharge (15, 16). However, Turon et al. showed that training
of cognitive functions presented on a television screen is feasible
and may be beneficial for critically ill patients (17).
In a previous study, we demonstrated that healthy participants
stimulated by nature videos through immersive VR in the
ICU were more relaxed after the stimulation. Additionally,
visual attention was not depleted during the course of the VR
stimulation (18). Our finding suggests that participants were
highly immersed and able to ignore the actual surroundings
and restore their visual attention. To our knowledge, it remains
unclear whether VR stimulation in critically ill patients would
produce physiological and psychological restorative effects
comparable with those observed in healthy participants.
The aim of this feasibility study in critically ill patients
was to investigate the acceptance, comfort, recollection, visual
perception and processing of immersive nature-related VR
stimulation, and how VR affects physiological parameters. We
hypothesized the following: firstly, that VR stimulation using
the new proposed method offers high usability, immersion and
satisfaction, is recollected and does not promote discomfort;
secondly, that patients would be able to perceive and process the
VR stimulation (i.e., visual attention) before and during their stay
in the ICU; thirdly, that VR stimulation will reduce physiological
markers of stress.
MATERIALS AND METHODS
Participant Recruitment
This study was approved by the Ethics Committee of the Canton
of Bern, Switzerland (KEK no. 2016-01652) and was registered at
Clinicaltrails.gov (no. NCT03025373). The required sample size
was calculated using the G∗Power 3 software (19) based on a
power of 80 and alpha error of 0.5. The effect size was estimated
as medium-large according to the classification by Cohen, on
the basis of our previous experience with VR stimulation in the
ICU (relaxing effect of the VR stimulation, i.e., physiological
measures), which was resulting in a sample size of 50 patients
(18). Inclusion criteria were age >18 years, no neurological
disorder, including delirium and planned elective open-heart
surgery. Patients were recruited on admission to the ICU between
17 April 2017 and 13 March 2018.
Procedure
The study was split into three phases (Table 1): (i) An initial
session 1 day prior to ICU admission (pre-ICU session), (ii)
TABLE 1 | Study procedure.
Tasks/variables Pre-ICU
session
ICU
session
Follow-up
session
Time since inclusion Day 1 Day 3 Day 90 (95%
CI 80.10)
Informed consent X
Demographic questionnaire X
VR stimulation X X X
Monitoring of physiological parameters X X X
Sedation level (RASS) X X X
Consciousness (GCS) X X X
Delirium (CAM-ICU) X
Cognitive functions (MOCA) X X
Health-related quality of life (EQ-5D-5L) X X
Questionnaire on acceptance, discomfort and
recollection
X
ICU, Intensive Care Unit; VR, Virtual reality; RASS, Richmond Agitation-Sedation Scale;
GCS, Glasgow Coma Scale; CAM-ICU, Confusion Assessment Method for the Intensive
Care Unit; MOCA, Montreal-Cognitive-Assessment.
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a second session the day after surgery (ICU session), and (iii)
a follow-up session ∼3 months after ICU discharge (follow-up
session). In the initial session, patients were briefed, signed the
informed consent, filled out questionnaires on demographics,
and health-related quality of life (EQ-5D-5L) (20) and cognitive
functions [Montreal-Cognitive-Assessment (MoCA) (21)] were
assessed. Patients were then prepared for the VR stimulation
by a study nurse, i.e., lying on the bed and monitoring of
physiological parameters. After 10min of rest, patients were
stimulated with the nature VR environment for 5min. Patients
were stimulated in the ICU the morning after surgery the
second time. Sedation level RASS, GCS, and delirium [Confusion
Assessment Method for the ICU, CAM-ICU (22)] were assessed
by trained ICU nurses. In the follow-up sessions, patients were
stimulated again and questioned about their memories of the
intensive care experience and acceptance, comfort and memories
of the VR stimulation. The assessment of cognitive functions
compared to the registered clinical trial a deviation exists.
Since the Consortium to Establish a Registry for Alzheimer’s
Disease (CERAD) (23) was too time consuming for patients
and had a too high workload instead the MoCA was used.
There is evidence that the MoCA assess cognitive functions at
a comparable level but is much shorter in time and needs less
workload (24).
Cognitive VR Stimulation
All measurements were conducted in a two to four-bed ICU
cubicle (Figure 2). The setup to stimulate patients consisted of
several elements: (i) a computer, a head-mounted display with
a built-in eye-tracker and noise canceling headphones, (ii) the
equipment to measure the physiological parameters, (iii) a noise-
signal monitor -positioned directly next to the patient- to register
noise >50 dB. The setup was audited by the Medical Technology
Department of the University Hospital of Berne for hygiene and
medical eligibility requirements and was approved thereafter for
use in ICU patients.
The VR stimulation consisted of a video presenting aquatic
worlds and landscapes for 5min. In addition, complementary
classical music was played through noise-canceling headphones.
The VR stimulation device (HTC Vive, High Tech Computer
Corporation, Taoyuan, Taiwan) is a head-mounted display and
was powered by a graphic card (NVIDIA GTX980, Nvidia, Santa
Clara, USA). Eye movements were sampled as fixation points
at a frequency of 250Hz inside the head-mounted display by
an eye tracker (SensoMotoric Instruments, Teltow, Germany).
During VR stimulation sessions, eye movements were streamed
to a second screen monitored by the investigators.
In all three sessions, heart and respiratory rates were
continuously monitored by five-lead electrocardiography at a
frequency of 240Hz (Carescape Monitor B650, GE Healthcare,
Little Chalfont, United Kingdom). In the pre-ICU and follow-
up sessions, the blood pressure was measured every 2min by a
cuff-based blood pressure monitor. After surgery, blood pressure
was continuously measured by an invasive intra-arterial blood
pressure monitor.
In the follow-up session the questionnaire on a 5-point scale
(from zero to four, Table 2) was used to assess acceptance,
comfort and recollection of the VR method during the ICU
session. Acceptance and, thus the sub domain immersion, was
assessed by questions from the Igroup Presence Questionnaire
(IPQ) (25), whereas usability and satisfaction were assessed
by questions from the System Usability Scale (SUS) (26). The
Simulator Sickness Questionnaire (SSQ) was used to assess the
level of discomfort during VR stimulation (27), and the ICU
Memory tool to assess recollection (28).
Statistical Analysis
Analyses were performed at the individual level, whereas eye
movements were measured as a collection of fixation points
(i.e., gaze data), where a fixation had a minimum duration
of 100ms and dispersed around 2 degrees (29). The number
of gazed moving objects outside the region of interest (e.g.,
TABLE 2 | Questionnaire on acceptance, discomfort, and recollection of the virtual reality stimulation during intensive care unit session.
No. Question (anchors) Sub-domain Domain Source
1 In the virtual world I had a sense of “being there” (Not at all—very much) Immersion Acceptance IPQ
2 I thought the system was easy to use (fully disagree—fully agree) Usability SUS
3 I felt very confident using the system (fully disagree—fully agree)
4 I think that I would like to use this system frequently (fully disagree—fully agree) Satisfaction
5 General discomfort (none—severe) Nausea Comfort SSQ
6 Stomach awareness (none—Severe)
7 Sweating (none—severe)
8 Nausea (none—severe)
9 Headache (none—severe) Oculomotor problems
10 Eye strain (None—severe)
11 Dizziness (none—severe) Disorientation
12 Do you recollect being in the intensive care unit (yes—no) Recollection of ICU Recollection ICU memory tool
13 Do you recollect the entire stay in the intensive care unit (yes—no)
14 Do you recollect the VR stimulation (yes—no) Recollection of VR stimulation -
ICU, Intensive Care Unit; VR, Virtual reality; IPQ, Igroup Presence Questionnaire; SSQ, Simulator Sickness Questionnaire; SUS, System Usability Scale.
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dolphin) was calculated. To analyze the time effect (visual
attention over time), the difference between the beginning
of stimulation (first 15 s) and the last 15 s of stimulation
was used and tested with one sample t-test against zero for
significance (two-sided). The differences in eye movement (i.e.,
mean fixation duration, number of fixations, number of gazed
meaningful moving objects and time fixated on one moving
object) between the three sessions were analyzed by one-way
analysis of variance (ANOVA) and Bonferroni adjustment as
a post hoc analysis. The same analysis was used to examine
health-related quality of life (i.e., EQ-5D-5L), cognitive functions
(i.e., MoCA) and whether VR stimulation had a relaxing effect
(decreasing physiological signs during stimulation). A one-sided
t-test (i.e., directed hypotheses) was used based on the findings
of our previous VR study (18) and the assumption that the
relaxing effect always involves a reduction in physiological signs.
For the questionnaire ratings, a one-sided t-test was used to
test whether the majority was above or below the midpoint
of the score scale. The data was analyzed using R (30) and
Matlab18b (31).
URL
A video of the immersive nature VR stimulation and a video
including the region of interest used in the analysis can be found
on our website http://www.artorg.unibe.ch/research/ger/group_
members/persons/gerber_stephan/index_eng.html#pane482606.
RESULTS
Demographics
A total of 57 patients undergoing heart surgery participated
in the study (Figure 1), and 33 patients (26 male) completed
all the sessions (Pre-ICU, ICU, and Follow up sessions). The
mean age of patients completing all the sessions was 63 years
(range 32–83 years). In all the VR stimulation sessions, patients
had a Glasgow Coma Score (GCS) (32) of 15 and a Richmond
FIGURE 1 | Flow of patients through the trial.
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FIGURE 2 | Patient during the stimulation in the ICU session, including setup and stimulation examples.
Agitation-Sedation Score (RASS) (33) of 0. In the second VR
treatment during the ICU stay, patients had, on average, an
APACHE II score of 22.3 (95% CI 20.3–24.2) and a SAPS II
of 53.4 (95% CI 48.1–58.6), and all were extubated [on average
within 8.1 h (95% CI 6.4–9.8)]. ICU length of stay was 0.9
days (95% CI 0.8–0.9). In the pre-ICU and follow-up sessions,
54.6 and 66.7%, respectively, of the patients received medication
influencing blood pressure, while 33.3 and 69.7%, respectively,
received medication influencing heart rate. During the ICU
session all patients received medication influencing the heart
rate, blood pressure and respiratory rate (i.e., antihypertensives
or catecholamines, analgesics, sedatives). Patients who did not
participate in all sessions were not considered in the final analysis
and were considered as drop-outs. All dropouts were unrelated
to the VR stimulation.
Acceptance, Discomfort, and Recollection
Questionnaire findings (range zero to four, Figure 3) revealed
that the VR stimulation was well accepted, easy to use and
appreciated by patients, as shown in the scores for high usability
3.57 (95% CI 3.3 to Inf., t(29) = 10.78, p < 0.001), immersion
2.70 (95% CI 2.3 to Inf., t(29) = 3.34, p < 0.001), and satisfaction
3.13 (95% CI 2.8 to Inf., t(29) = 5.32, p < 0.001). Symptoms of
discomfort during stimulation, such as disorientation 0.03 (95%
CI -Inf. to 0.09, t(29) =−59.00, p < 0.001), oculomotor problems
0.15 (95% CI -Inf. to 0.24, t(29) =−34.00, p < 0.001), and nausea
0.04 (95% CI -Inf. to 0.04, t(29) = −72.46, p < 0.001) were rated
low on the score scale.
Based on results of the ICUMemory tool, 28 of the 33 patients
(84.8%) were able to recollect the content of the stimulation (e.g.,
elephant, yellow fish, ocean, dolphin, polar bear, and mountains),
23 patients had a weak recollection of their stay in ICU, and 10
patients (30.3%) had a clear recollection of the whole stay in ICU.
Moreover, during the VR stimulation no noise>50 dB or adverse
events were registered.
Eye Movements
Visual fixation duration was significantly higher during the ICU
session compared to the pre-ICU (p < 0.001) and follow-up
sessions (p < 0.001), as seen in Table 3. The number of fixations
were significantly lower during the ICU session compared to pre-
ICU (p < 0.001) and follow-up sessions (p < 0.001), whereas
no significant difference was found between the pre-ICU and
follow-up sessions. The number of gazed meaningful moving
objects per minute (Figure 3) was significantly lower in the ICU
session compared to the pre-ICU (p < 0.001) and follow-up
sessions (p= 0.026), whereas the time fixated on one meaningful
moving object did not show any significant difference. Analysis
showed that the change in visual fixation duration over time
within a session was not significant in any of the three sessions
and remained constant.
Physiological Parameters
Compared to the initial measurement at the beginning of the
stimulation (first 15 s) and the last 15 s of the stimulation,
the respiratory rate decreased significantly in all three sessions
(Figure 3 and Table 4). The significant reduction in respiratory
rate by using a directed hypothesis was −1.34 breath/min in
the pre-ICU session, −0.56 breath/min in the ICU session
and −1.88 breath/min in the follow-up session. Analysis of
variance demonstrated no significant differences between the
three sessions [F(2, 84) = 0.97, p = 0.384]. No significant
reduction or differences were observed during the three sessions
in heart rate [F(2, 86) = 0.49, p = 0.615] and blood pressure
[F(2, 77) = 0.22, p < 0.803]. Furthermore, the medication did not
have any influence on the analysis.
Health-Related Quality of Life and
Cognitive Functions
The health-related quality of life between the pre-ICU (M =
78.00, SD = 13.27) and follow-up sessions (M = 85.24, SD =
9.52) increased significantly by 7.03 (95% CI 1.26–12.81, t(31)
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FIGURE 3 | The questionnaire scales on the left show the perception of the virtual reality (VR) stimulation by critically ill patients during their Intensive Care Unit (ICU)
stay. The relaxing effect and visual processing are shown on the right. Acceptance, discomfort and recollection were assessed in the follow-up session, whereas visual
processing and the relaxing effect were measured in all three sessions. Overall, the new method was well accepted, did not trigger any discomfort, produced a
decreasing respiratory rate during stimulation, and the patients were able to process the stimulation.
TABLE 3 | Eye movements during the three sessions.
Variables Session Fixation duration (ms) Number of fixations (no./min) No. of gazed meaningful moving objects
(no. obj./min)
Time fixating an
object (s)
Mean (SD) Pre-ICU 364 (67) 595 (95) 48.1 (8.2) 0.92 (0.2)
Mean (SD) ICU 434 (119) 351 (130) 38.1 (10.5) 0.88 (0.3)
Mean (SD) Follow-up 372 (68) 573 (109) 44.0 (8.0) 0.97 (0.2)
ANOVA F (2, 92) = 6.21
p = 0.003
F (2, 95) = 46.68
p < 0.001
F (2, 94) = 10.12
p < 0.001
F (2, 94) = 1.01
p = 0.369
Adj. p-val.* Pre—Fol. 1.00 1.00 0.214
Adj. p-val.* Pre—ICU <0.001 <0.001 <0.001
Adj. p-val.* ICU—Fol. <0.001 <0.001 0.026
SD, Standard Deviation; Adj., Adjusted; Pre., pre-ICU session; ICU, ICU session; Fol., follow-up session; *Bonferroni correction. The bold values indicate to significant results.
= 2.48, p < 0.019). No significant differences were found in
cognitive functions between the pre-ICU (M= 27.52, SD= 2.01)
and follow-up sessions (M= 27.56, SD= 2.02).
DISCUSSION
Primary Results
Consistent with our first hypothesis, our results indicate that
VR stimulation was pleasant, immersive, and easy to use.
Furthermore, VR stimulation did not promote discomfort.
Secondly, critically ill patients were able to perceive and
process VR stimulation in the ICU session, whereas on a
lower level compared to the pre-ICU and follow-up sessions.
Thirdly, VR stimulation decreased the respiratory rate, which
can be interpreted as a sign of relaxation, produced by
isolating and protecting critically ill patients from the noisy and
stressful environment.
Acceptance, Comfort, and Recollection
Firstly, VR stimulation was highly appreciated and accepted by
critically ill patients as reflected in high usability and satisfaction
scores close to the maximum of the respective scales. Immersion
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TABLE 4 | Respiratory rate during the three sessions.
Variables Pre-ICU session
(breath/min)
ICU session
(breath/min)
Follow-up session
(breath/min)
Mean Start (SD) 21.16 (4.68) 21.32 (3.57) 19.23 (4.91)
Mean End (SD) 19.82 (4,67) 20.76 (2.78) 17.35 (3.70)
Difference End
Start (SD)
−1.34 (3.93) −0.56 (1.79) −1.88 (4.65)
T-test t (28) = −1.84,
p = 0.039
t (29) = −1.72,
p = 0.048
t (28) = −2.14,
p = 0.021
SD, Standard Deviation. The bold values indicate to significant results.
was also highly scored, thus indicating that patients forgot about
their actual surroundings. This may underline the fact that
sensory overload and deprivation (stress and noise of the ICU
environment) can be reduced during VR stimulation.
Furthermore, VR stimulation did not evoke any negative
reactions, but provided patients with a confident, secure,
fascinating and familiar environment. Almost 85% of all critically
ill patients had clear memories of the VR stimulation during the
ICU stay, as indicated by remembered content. However, only
one third of the patients had clear memories of their stay in the
ICU. The low recollection of the ICU stay was potentially caused
by the psychological phenomenon of fading affect bias, which
causesmemories of negative events like the ICU stay to fade faster
than the pleasant VR stimulation (34–36). These results and the
low withdrawal rate of four patients further confirms that VR
stimulation was highly appreciated, captured patients’ attention
and distracted them from the stressful and noisy ICU.
Eye Movements
Visual fixation duration was significantly higher in the ICU
session compared to pre-ICU and follow-up sessions. In contrast,
the number of fixations was significantly lower in the ICU
session, indicating that patients needed more time to process
the information and had less visual exploration. This means
that patients were experiencing post-surgery fatigue (i.e., reduced
level of attention), potentially caused by medication (e.g.,
analgesics to reduce pain) and sleep-deprivation. Visual fixation
duration and the number of fixations in the pre- and follow-up
session were in line with VR stimulation in healthy volunteers
(18) and findings when viewing dynamic natural scenes on a
screen (37).
Additionally, post-surgery fatigue was also reflected in the
number of gazed meaningful moving objects inside the video,
which was significantly lower in the ICU session, but still at a
high level of almost 40 objects a minute. It is noteworthy that
there were no significant differences between the times fixating
meaningful objects, confirming the second finding that patients
were able to perceive, process, and follow the objects during
all three sessions, although to a lesser extent during the ICU
session. In line with the Attention Restoration Theory, the results
suggest that critically ill patients are able to recover and restore
attentional fatigue during VR nature stimulation by fostering
low-effort attention (38, 39).
Physiological Parameters
The third main finding was that the respiratory rate decreased
significantly during all three sessions, whereas heart rate
and blood pressure were not significantly influenced by the
stimulation. Consistent with the Stress Recovery Theory, the VR
stimulation had a relaxing effect on the parasympathetic nervous
system. The decrease in respiratory rate during stimulation
may indicate that nature-related VR stimulation can reduce
stress and mental fatigue in critically ill patients by sealing off
and protecting them from the noisy and stressful environment
(14, 40).
One explanation why the significant relaxing effect was only
seen in the respiratory rate was that more than 50% of all patients
received medication affecting the heart rate and blood pressure,
which influenced and thus stabilized and minimized the relaxing
effect. Furthermore, the smaller decrease in the respiratory
rate during the ICU session was probably due to medication
influencing the respiratory rate, which was not administered in
the pre-ICU and follow-up sessions.
Health-Related Quality of Life and
Cognitive Functions
In the follow-up session, health-related quality of life was
significantly higher compared to the pre-ICU session, indicating
that they profited from the surgery, whereas no significant
differences were found for cognitive functions. Therefore, in line
with the literature, the short stay in the ICU did not have a
negative effect on long-term cognitive functions (4, 5).
Limitations and Outlook
It remains unclear whether our findings can be generalized
to a general population of critically ill patients. Moreover, as
patients need to be awake, VR stimulation may not be suitable
for critically ill patients who are unconscious and deeply sedated.
In addition, it is unclear which part of the positive relaxing
effect was due to the head-mounted display and which part due
to the noise-canceling headphones. If the relaxing effect was
due to noise reduction, VR stimulation might additionally help
distract patients from their current condition and daily routine
and thus has a positive effect on well-being. Therefore, the main
limitations of this study design are the lack of a control group
(i.e., sham intervention), the selected patient population (i.e., no
patients were included in the study with prolonged ICU stay and
mechanical ventilation) and the lack of repeated VR stimulation
during ICU stay (i.e., long-term effects).
In this study, we showed that patients can be protected from
the noisy and stressful environment. Further randomized clinical
trials should investigate whether the proposed VR stimulation
reduces functional and long-term cognitive impairment and
improves health-related quality of life after ICU stay. Since
long-term cognitive impairment is associated with delirium,
studies should also focus on whether VR stimulation can
potentially reduce the incidence and the duration of delirium (5).
Furthermore, it remains unclear how long and how many times
a day VR stimulation should be employed. We suggest including
VR stimulation at least twice in the daily routine. If applicable,
Electroencephalogram monitoring should be considered as a
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further means of measuring the effect of VR stimulation in
critically ill patients.
CONCLUSION
Our results indicate that the newly developed VR stimulation
method was well accepted, immersive and appreciated by
critically ill patients, and that VR was recollected better than
the rest of the ICU stay. Furthermore, VR stimulation may
have had a relaxing and calming effect, was easy to use and
did not evoke discomfort. Eye movement analysis indicated
that critically ill patients were able to perceive and process
the stimulation in all sessions. Thus, VR stimulation has the
potential of becoming a new method to reduce long-term
cognitive impairment and comfort critically ill patients during a
stay in ICU.
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